Loading clinical trials...

UNKNOWNPHASE4

Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.

Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis. Measurement With Sensory and Quantitive Functional Tests and Concordance Analysis With Subjective Scales of Pain.

NCT01233739•Juan A. Arnaiz

View on ClinicalTrials.gov

Summary

Patients who present rhizarthrosis diagnostic will be randomized to be treated with chondroitin sulfate or placebo during 24 weeks to study the effect of the treatment with objective and subjective indicators of pain and sensibility.

Eligibility

Age

45 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•both sex patients
•age between 45 to 75 years
•with mechanical pain at the trapezium-thumb metacarpal joint of more than 3 months duration
•grade II or III Eaton \& Glickel rhizarthrosis radiological diagnose
•pain at inclusion of \>= 40 mm at a visual analogue scale
•without rehabilitation treatment or infiltration in the last 6 months
•who accept to participate and sign informed consent

Exclusion Criteria

•patients with rhizarthrosis resulted from rheumatic disease
•patients with joint surgery or traumatic background
•illiterate patients or unable to understand informed consent
•patients with previous neuropsychopathology enough severe to unable participation at the study
•patients with peripheral sensory impairment due to diabetes, peripheral neuropathy or central neurological sequelae of disease in the affected limb that can alter sensory perception
•patients with coagulopathy
•inflammation for other process at the joint at study
•in treatment with non-steroidal anti-inflammatory drug in the last 7 days and/or corticosteroid in the last 30 days
•allergy or hypersensibility at chondroitin sulfate or its excipients
•pregnant or breastfeeding woman

Locations (1)

Hospital Clínic i Provincial de Barcelona

Barcelona, Catalonia, Spain

Key Dates

Start Date

March 1, 2011

Primary Completion Date

April 1, 2013

Completion Date

April 1, 2013

Last Updated

February 22, 2013

Enrollment

108

ESTIMATED participants

Conditions

Rhizarthrosis

Interventions

Chondroitin sulfate

DRUG

Placebo

DRUG

Contacts

Judit Pich, Pharmacist

CONTACT

+34 93 227 54 00 jpich@clinic.ub.es

Pinch Grip and Functional Outcomes Between Hematoma Distraction Arthroplasty Versus Ligament Reconstruction Tendon Interposition Arthroplasty in Trapeziometacarpal Osteoarthritis.

NCT06858800

Osteoarthritis ThumbsRhizarthrosis+1 more

View study

COMPLETEDNA

Biological Characterization Study of an Autograft Nanofat (Nanocarabio)

NCT05915962

Rhizarthrosis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 22, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.

Inclusion Criteria

Exclusion Criteria

Pinch Grip and Functional Outcomes Between Hematoma Distraction Arthroplasty Versus Ligament Reconstruction Tendon Interposition Arthroplasty in Trapeziometacarpal Osteoarthritis.

Biological Characterization Study of an Autograft Nanofat (Nanocarabio)

Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis

Saline Lavage X Saline Lavage and Osteonil® Mini in Rizarthritis